Budesonida para el tratamiento de la colitis linfocítica

Referencias

1. Münch A, Aust D, Bohr J, et al; European Microscopic Colitis Group (EMCG). Microscopic colitis: current status, present and future challenges: statements of the European Microscopic Colitis Group. J Crohns Colitis 2012; 6:932–945.

2. Nyhlin N, Wickbom A, Montgomery SM, et al. Long-term prognosis of clinical symptoms and health-related quality of life in microscopic colitis: a case-control study. Aliment Pharmacol Ther 2014;39:963–972.

3. Fumery M, Kohut M, Gower-Rousseau C, et al. Incidence, clinical presentation and associated factors of microscopic colitis in Northern France: a populationbased study. Dig Dis Sci 2017;62:1571–1579.

4. Kane JS, Rotimi O, Ford AC. Macroscopic findings, incidence and characteristics of microscopic colitis in a large cohort of patients from the United Kingdom. Scand J Gastroenterol 2017;52:988–994.

5. Bjørnbak C, Engel PJ, Nielsen PL, et al. Microscopic colitis: clinical findings, topography and persistence of histopathological subgroups. Aliment Pharmacol Ther 2011;34:1225–1234.

6. Bonderup OK, Wigh T, Nielsen GL, et al. The epidemiology of microscopic colitis: a 10-year pathology-based   Scand J Gastroenterol 2015;50:393–398.

7. Williams JJ, Kaplan GG, Makhija S, et al. Microscopic colitis-defining incidence rates and risk factors: a population-based study. Clin Gastroenterol Hepatol 2008;6:35–40.

8. Stewart M, Andrews CN, Urbanski S, et al. The association of coeliac disease and microscopic colitis: a large population-based study. Aliment Pharmacol Ther 2011; 33:1340–1349.

9. Abboud R, Pardi DS, Tremaine WJ, et al. Symptomatic overlap between microscopic colitis and irritable bowel syndrome: a prospective study. Inflamm Bowel Dis 2013; 19:550–553.

10. Gu HX, Zhi FC, Huang Y, et al. Microscopic colitis in patients with chronic diarrhea and normal colonoscopic findings in Southern China. Int J Colorectal Dis 2012; 27:1167–1173.

11. Rasumssen MA, Munck LK. Systematic review: are lymphocytic colitis and collagenous colitis two subtypes of the same disease–microscopic colitis? Aliment Pharmacol Ther 2012;36:79–90.

12. Nguyen GC, Smalley WE, Vege SS, et al; Clinical Guidelines Committee. American Gastroenterological Association Institute Guideline on the medical management of microscopic colitis. Gastroenterology 2016; 150:242–246.

13. American Gastroenterological Association. AGA Institute Guideline on the Management of Microscopic Colitis: clinical decision support tool. Gastroenterology 2016; 150:276.

14. Miehlke S, Madisch A, Karimi D, et al. Budesonide is effective in treating lymphocytic colitis: a randomized double-blind placebo-controlled study. Gastroenterology 2009;136:2092–2100.

15. Pardi DS, Loftus EV, Tremaine WJ, et al. A randomized, double-blind, placebo-controlled trial of budesonide for the treatment of active lymphocytic colitis. Gastroenterology 2009;136(Suppl 1):A519–A520.

16. Calabrese C, Fabbri A, Areni A, et al. Mesalazine with or without cholestyramine in the treatment of microscopic colitis: randomized controlled trial. J Gastroenterol Hepatol 2007;22:809–814.

17. Chande N, Al Yatama N, Bhanji T, et al. Interventions for treating lymphocytic colitis. Cochrane Database Syst Rev 2017;7:CD006096.